A research team based in Kumamoto University (Japan) has created complex 3D kidney tissue in the lab solely […]

Artificial intelligence (AI)-based scheduling significantly improves physician engagement and reduces burnout by creating fair and flexible schedules that […]

As hospitals in the US and elsewhere fill again with patients with covid-19, discussions about how to fairly […]

The image of Queen Elizabeth II sitting alone in a black facemask at the funeral of her husband […]

The UK government is taking a fresh look at gambling. A white paper, expected in spring 2022, will […]

Ayvakyt receives a positive opinion from the CHMP for the treatment of adults with advanced systemic mastocytosis

Market authorisation for twice yearly schizophrenia treatment which offers patients much-needed medication continuity

Novartis’ Sandoz reportedly the target of $25B buyout bid from Carlyle and Blackstone fkansteiner Tue, 02/01/2022 – 11:09

Novartis, Amgen settle their dueling lawsuits over migraine drug Aimovig esagonowsky Tue, 02/01/2022 – 10:36

Biogen’s Aduhelm support campaign backfires as CMS receives many more comments in favor of restrictive coverage: analyst fkansteiner […]